Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

MLA

Stenestrand, Ulf, et al. “Safety and Efficacy of Drug-Eluting vs. Bare Metal Stents in Patients with Diabetes Mellitus: Long-Term Follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).” European Heart Journal, vol. 31, no. 2, Jan. 2010, pp. 177–86. EBSCOhost, https://doi.org/10.1093/eurheartj/ehp424.

APA

Stenestrand, U., James, S. K., Lindbäck, J., Fröbert, O., Carlsson, J., Scherstén, F., Nilsson, T., & Lagerqvist, B. (2010). Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). European Heart Journal, 31(2), 177–186. https://doi.org/10.1093/eurheartj/ehp424

Chicago

Stenestrand, Ulf, Stefan K James, Johan Lindbäck, Ole Fröbert, Jörg Carlsson, Fredrik Scherstén, Tage Nilsson, and Bo Lagerqvist. 2010. “Safety and Efficacy of Drug-Eluting vs. Bare Metal Stents in Patients with Diabetes Mellitus: Long-Term Follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).” European Heart Journal 31 (2): 177–86. doi:10.1093/eurheartj/ehp424.